BioCentury
ARTICLE | Company News

Management tracks: Silence, Apeiron

July 17, 2018 11:12 PM UTC

RNA therapeutics company Silence Therapeutics plc (LSE:SLN) hired David Horn Solomon as CEO. He was CEO at Akari Therapeutics plc (NASDAQ:AKTX).

Immuno-oncology company Apeiron Biologics AG (Vienna, Austria) said CEO Hans Loibner has retired. The company named CFO and CBO Peter Llewellyn-Davies as the new CEO...